Surgery Partners, Inc. (NASDAQ:SGRY) CFO David T. Doherty Sells 13,641 Shares of Stock

Surgery Partners, Inc. (NASDAQ:SGRY) CFO David T. Doherty sold 13,641 shares of the company’s stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.61, for a total transaction of $349,346.01. Following the sale, the chief financial officer now directly owns 108,862 shares of the company’s stock, valued at $2,787,955.82. This represents a 11.14 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Surgery Partners Stock Performance

Shares of SGRY stock opened at $25.58 on Tuesday. The firm has a market cap of $3.25 billion, a P/E ratio of -53.29, a PEG ratio of 17.77 and a beta of 2.60. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $35.29. The stock’s 50-day moving average is $21.84 and its two-hundred day moving average is $26.93.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company’s quarterly revenue was up 14.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.15 EPS. Analysts predict that Surgery Partners, Inc. will post 0.71 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Bank of America assumed coverage on shares of Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 price target on the stock. Royal Bank of Canada reduced their target price on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a report on Wednesday, November 20th. Macquarie reiterated an “outperform” rating and set a $34.00 price target on shares of Surgery Partners in a report on Tuesday, November 19th. JPMorgan Chase & Co. reduced their price objective on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. Finally, UBS Group assumed coverage on Surgery Partners in a research note on Monday, October 14th. They set a “buy” rating and a $38.00 target price on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $36.56.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of SGRY. Principal Financial Group Inc. bought a new stake in Surgery Partners in the third quarter worth $1,469,000. King Street Capital Management L.P. bought a new stake in shares of Surgery Partners during the 3rd quarter worth about $46,748,000. Royce & Associates LP increased its holdings in shares of Surgery Partners by 12.2% during the 3rd quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock valued at $16,451,000 after acquiring an additional 55,545 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Surgery Partners by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock valued at $60,117,000 after acquiring an additional 42,897 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in Surgery Partners by 140.4% in the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock worth $42,892,000 after purchasing an additional 777,038 shares during the last quarter.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.